Role of MAP‐K pathway and oncogenic BRAF mutations in metastatic melanoma

Aldo Del Col, Multiple Myeloma patient and Founder of Myeloma Canada

Multiple Myeloma: Understanding Through Advocacy

Nicholas Cross, MA, PhD, FRCPath Professor of Human Genetics Director, Wessex Regional Genetics Laboratory Salisbury District Hospital, Salisbury, UK

Introduction to the Cause of CML

JAK Mechanism of Action

Clare Stuart: TS Australia, Robert Grandia: TSC patient, Patricia Nolan: TSC Canada

TSC Common Threads: TSC Affects Each Person Differently

Featured Videos